-
1 Comment
Hainan Shuangcheng Pharmaceuticals Co., Ltd is currently in a long term downtrend where the price is trading 3.9% below its 200 day moving average.
From a valuation standpoint, the stock is 35.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.2.
Hainan Shuangcheng Pharmaceuticals Co., Ltd's total revenue sank by 0.9% to $76M since the same quarter in the previous year.
Its net income has dropped by 118.6% to $-9M since the same quarter in the previous year.
Finally, its free cash flow grew by 90.9% to $15M since the same quarter in the previous year.
Based on the above factors, Hainan Shuangcheng Pharmaceuticals Co., Ltd gets an overall score of 2/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100001K63 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Beta | 0.26 |
|---|---|
| Market Cap | 4B |
| Target Price | None |
| PE Ratio | None |
| Dividend Yield | None |
Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Haikou, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002693.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
